Purpose:
The purpose of this Funding Opportunity Announcement (FOA) is to encourage cooperative agreement (U54) applications from multi-disciplinary groups of investigators to accelerate the rate of progress in determining the functional, pharmacological, neuronal network and whole animal consequences of genetic variants discovered in individuals with various types of epilepsy and to develop strategies for establishing diagnostic criteria and identifying potential targets for intervention.
Funding Available:
NINDS intends to commit $1,500,000 direct costs in FY 2019 to fund one award.
Key Dates:
Posted Date: May 13, 2019
Open Date (Earliest Submission Date): July 27, 2019
Letter of Intent Due Date(s): July 27, 2019
Application Due Date(s): August 27, 2019, by 5:00 PM local time of applicant organization.
Filed Under: Funding Opportunities